Determining seropositivity-A review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases.
YuYen ChanKimberly M FornaceLindsey WuBenjamin F ArnoldJeffrey W PriestDiana L MartinMichelle A ChangJackie CookGillian StresmanChris J DrakeleyPublished in: PLoS neglected tropical diseases (2021)
For disease control programmes, seropositivity is a practical and easily interpretable health metric but determining appropriate cut-offs for positivity can be challenging. Considerations for optimal cut-off approaches should include factors such as methods recommended by previous research, transmission dynamics, and the immunological backgrounds of the population. In the absence of international standards for estimating seropositivity in a population, the use of consistent methods that align with individual disease epidemiological data will improve comparability between settings and enable the assessment of changes over time.